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Abstract
This study sought to investigate the ameliorative effects of ethanol extract Artocarpus heterophyllus (EAH) in alloxan-induced diabetic
rats. The ratswere divided into 6 groups, with groups 1 and 2 serving as nondiabetic and diabetic control, respectively; group 3 serving
as diabetic rats treated with 5 mg/kg glibenclamide; and groups 4 to 6 were diabetic rats treated with 50, 100, and 150 mg/kg of EAH,
respectively. Assays determined were serum insulin, lipid peroxidation, and antioxidant enzyme activities. EAH stem bark reduced
fasting blood glucose and lipid peroxidation levels and increased serum insulin levels and activities of antioxidant enzymes. Data
obtained demonstrated the ability of EAH stem bark to ameliorate pancreatic b-cell dysfunction in alloxan-induced diabetic rats.
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Diabetes mellitus is a chronic metabolic disease that affects
more than 7.5% of the world population.1 It is caused by an
inherited or acquired deficiency of insulin secretion that results
in an increased blood glucose level, which in turn produces
adverse effects on different body systems.2 There are limitations
to currently available drugs, which merit the consideration of
new agents, especially in the form of herbal medicine with the
potential for greater efficacy or fewer side effects.3
The practice of traditional medicine is as old as the origin of
man.4 The use of plants in traditional medicine falls outside the
mainstream of Western or Orthodox medicine. It has been
shown that two thirds of the world population (mainly in devel-
oping countries) rely on traditional medicine for their health
care.5 Some plants have been used in the treatment and man-
agement of diabetes such as Ricinus communis among others.4
Also, the use of Artocarpus heterophyllus leaf has been
documented.6
In addition, several reports have cited the antidiabetic
effects of the root and fruit of Artocarpus heterophyllus,
which could be attributed to its high antioxidant contents.6
Furthermore, it has been reported locally that the stem of
Artocarpus heterophyllus is useful in the management of
diabetes. In this context, the present study aimed to ascertain
the acclaimed reports.
Materials and Methods
Plant Material, Authentication, and Processing
The Artocarpus heterophyllus stem bark was obtained from a nearby
farm in the outskirts of Ibadan. It was identified and authenticated at
the herbarium of the Department of Botany, University of Ibadan, Oyo
State, Nigeria.
Thereafter, the air-dried Artocarpus heterophyllus stem bark was
powdered in an electric blender and soaked in 500 mL 70% ethanol
until exhaustion, followed by filtration to yield the ethanol extract,
which was evaporated until dryness under reduced pressure and called
EAH (ie, ethanol extract of Artocarpus heterophyllus).
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Experimental Animals
Thirty male Wistar rats weighing 150 to 200 g were used in this study.
These animals were obtained from the Animal House, Afe Babalola
University, and were maintained under standard conditions of tem-
perature (24+ 5C). All animals were allowed free access to standard
laboratory food and water 7 days before starting the experiment and
during the period of the experiment. All animals were fed with pelle-
tized diet and water ad libitum.
Chemicals
Chemicals and reagents were procured from Sigma-Aldrich, Inc (St
Louis, MO). All enzyme assay kits were products of Randox Labora-
tories Ltd, Antrim, UK. All other chemicals were of analytical grade
and prepared in all-glass apparatus using sterilized distilled water.
Induction of Diabetes
Diabetes was induced in the rats by a single intraperitoneal injection of
freshly prepared alloxan of 150 mg/kg body weight in normal saline.
Two days after alloxan administration, blood samples were obtained
from the tips of the rat’s tail and the fasting blood glucose levels were
determined using OneTouch Ultra glucometer (LifeScan, USA) to
confirm diabetes. The diabetic rats exhibiting blood glucose levels
greater than or equal to 200 mg/mL were included in this study as
reported earlier.7,8
Doses Selected
Thedose selection for theEAHstembarkwas foundedon the acute toxicity
study, which did not show any adverse effect following oral administration
of doses up to 3500 mg/kg. According to modified method of Ojo et al,9
experimental oral doses of 50, 100, and 150 mg/kg of the maximum pos-
sible dose of the extract was selected based on the acute toxicity study.
Animal Grouping
Rats were divided randomly into 6 groups with 5 animals in each and
treated as follows:
ND: Control rats received distilled water.
D: Alloxan-induced diabetic rats received distilled water.
GLI5: Diabetic rats received glibenclamide (5 mg/kg body weight).
EHA50: Diabetic rats received 50 mg/kg body weight EHA.
EHA100: Diabetic rats received 100 mg/kg body weight EHA.
EHA150: Diabetic rats received 150 mg/kg body weight EHA.
Collection and Treatment of Blood Samples
The animals were sacrificed on the 21st day, after oral administration
of EAH for 20 days. Blood samples were collected into plain sample
tubes for serum analysis by cervical dislocation of the animals.
Preparation of Serum
The blood samples were allowed to stand at room temperature for 30
minutes to form clot after which it was centrifuged at 3000g for 15
minutes. After centrifugation, the clot formed a sediment at the bottom
of the centrifuge tube, and the supernatant, which is the serum, was
collected using a Pasteur’s pipette. The serum thus obtained was
appropriately labelled and stored until use for further analysis.
Preparation of Tissue Homogenates
The rats were decapitated using cervical dislocation and the liver was
rapidly excised and placed on ice and weighed. The liver tissues were
subsequently homogenized in cold Tris-HCl buffer (1:10 w/v) with
about 10 strokes at approximately 1200 rev/min in a centrifuge. The
homogenate was centrifuged for 10 minutes at 3000g to yield a pellet
that was discarded, and a low-speed supernatant, which was kept for
lipid peroxidation assay.10
Determination of Fasting Blood Sugar
Fasting blood sugar was determined using the Accu-check Advan-
tage II Clinical Glucose meter.11 In this method, blood was collected
from the tips of the rats’ tails and a drop placed on the indicator
portion of the Accu-check strip to determine the fasting blood glu-
cose level of each rat.
Determination of Serum Insulin and Homeostatic Model
Assessment Scores
This was assayed by enzyme-linked immunosorbant assay (ELISA).12
The serum insulin concentrations were measured by an ELISAmethod
using an ultrasensitive rat insulin ELISA kit (Mercodia, Uppsala,
Sweden) in a multiplate reader. The absorbance for the calibrators
(except for calibrator 0) was plotted against their concentration by
using an appropriate computer program (MS Excel) with a display
of the equation of the curve. The equation was then used to calculate
the concentration of insulin in the samples.
Also, homeostatic model assessment (HOMA-IR and HOMA-b)
scores were calculated at the end of the intervention according to the
following formula:
HOMA-IR ¼ ½ðFasting serum insulin in U=L
Fasting blood glucose in mmol=LÞ=22:5
HOMA-b ¼ ðFasting serum insulin in U=L
20=Fasting blood glucose in mmol=L 3:5Þ
Conversion factor : insulin ð1 U=L ¼ 7:174 pmol=LÞ
Determination of Lipid Peroxidation
Lipid peroxidation was determined according to the method described
by Adam-Vizi and Seregi.13 An aliquot of 0.4 mL of the sample was
mixed with 1.6 mL of Tris-KCl buffer to which 0.5 mL of 30% TCA
was added. Then 0.5 mL of 0.75% TBA was added and placed in a
water bath for 45 minutes at 80C. This was then cooled in ice and
centrifuged at 3000g for 5 minutes. The clear supernatant was col-
lected and the absorbance was measured against a reference blank of
distilled water at 532 nm. The malondialdehyde level was expressed as
units/mg protein.
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Determination of Catalase (CAT) Activity
The catalase activity of the homogenates was determined according to
the method described by Sinha.14 One millimeter of the supernatant
fraction of the homogenate was mixed with 19 mL distilled water to
give a 1:20 dilution. The assay mixture contained 4 mL of hydrogen
peroxide solution (800 mmol) and 5 mL of phosphate buffer at pH 7.0
in a 10-mL flat bottom flask. Thereafter, 1 mL of the properly diluted
sample was rapidly mixed with the reaction mixture by a gentle
swirling motion at room temperature. Then 1-mL portion of the
reaction mixture was withdrawn and blown into 2 mL dichromate/
acetic acid reagent at 60-second intervals. The hydrogen peroxide
contents of the withdrawn sample were determined by reading the
absorbance at 570 nm.
Determination of Superoxide Dismutase (SOD) Activity
The SOD activity in the liver was determined according to the method
described by Misra and Fridovich.15 An aliquot of the sample was
added to 2.5 mL of 0.05 M carbonate buffer (pH 10.2) to equilibrate
in the spectrophotometer. The reactions were initiated by the addition
of 0.3 mL freshly prepared 0.3 mM adrenaline to the mixture which
was quickly mixed by inversion. The reference cuvette contained 2.5
mL buffer, 0.3 mL of adrenaline, and 0.2 mL of water. The increase in
absorbance at 480 nm every 30 seconds was monitored.
Glutathione Peroxidase (GPx) Assay
The method described by Rotruck et al16 was employed for this deter-
mination. The reaction mixture containing 500 mL phosphate buffer,
100 mL sodium azide, 200 mL of GSH, and 100 mL of H2O2 was added
to 500 mL of the sample, after which 600 mL of the sample was added
and thoroughly mixed. The whole reaction mixture was incubated at
37C for 3 minutes after which 0.5 mL TCA was added and thereafter
centrifuged at 3000g for 5 minutes. To 1 mL of each of the super-
natants, 2 mL of K2HPO4 and 1 mL DTNB was added and the absor-
bance was read at 412 nm against a blank.
Histopathological Studies
The tissues were fixed in formalin. They were dehydrated in ascending
grades of ethanol, cleared in xylene, and processed to paraffin blocks,
sectioned (5 mm thick), and stained with hematoxylin and eosin stain.
They were examined using light microscopy for demonstration of
pathological changes in tissues, which included atrophy, cell destruc-
tion, and necrosis.17
Data analysis
All data are expressed as the mean of 5 replicates+ standard error of
mean. Statistical evaluation of data was performed by SPSS version
16. Using one-way analysis of variance, followed by Dunett’s post hoc
test for multiple comparisons, values were considered statistically
significant at P < .05 (confidence level ¼ 95%).18
Results
The effect of EAH stem bark on fasting blood glucose is shown
in Table 1. After 48 hours of diabetes induction, fasting blood
glucose levels in the 5 experimental groups D, GLI5, EHA50,
EHA100, and EHA150 were significantly higher when
compared to the control group (ND). After 3 weeks of treat-
ment, a significant reduction in fasting blood glucose levels
was observed in diabetic rats treated with glibenclamide and
with the 3 doses of EHA in comparison with the untreated
diabetic animals (group D).
Table 2 shows the effect of the EAH stem bark on serum
insulin, HOMA-IR, and HOMA-b in alloxan-induced dia-
betic rats. Serum insulin and HOMA-b levels were statisti-
cally reduced, and HOMA-IR increased in alloxan-induced
diabetic rats (group D) when compared to control animals
(Table 2). The comparison of the diabetic groups treated
with glibenclamide or EHA revealed significant increase
of the parameters serum insulin and HOMA-b and decrease
of HOMA-IR.
Furthermore, a HOMA-IR level was increased on induction
of diabetes, as shown in Table 2 (diabetes control group). A
Table 1. Effect of Ethanol Extract of Artocarpus heterophyllus on Fast-
ing Blood Glucose Levels of Alloxan-Induced Diabetic Rats*.
Groups
Initial Fasting
Blood
Glucose Level
(mg/dL)
Fasting Blood
Glucose Level
(mg/dL) at 48 Hours
of Alloxan Induction
Fasting Blood
Glucose Level
(mg/dL) at 3 Weeks
of Treatment
ND 83.60 + 1.20a 83.46 + 0.10a 84.40 + 1.10a
D 84.10 + 0.08a 238.00 + 0.10b 308.12 + 1.10e
GLI5 82.40 + 0.10a 313.00 + 2.10c 98.10 + 1.00d
EHA50 82.89 + 0.16a 324.00 + 1.20d 94.30 + 1.10c
EHA100 83.20 + 0.09a 335.00 + 2.10d 88.40 + 1.12b
EHA150 83.40 + 0.06a 346.00 + 3.40e 84.20 + 1.46a
Abbreviations: ND, control rats received distilled water; D, alloxan-induced
diabetic rats received distilled water; GLI5, Diabetic rats received glibencla-
mide (5 mg/kg body weight); EHA50, diabetic rats received 50 mg/kg body
weight EHA; EHA100, diabetic rats received 100 mg/kg body weight EHA;
EHA150, diabetic rats received 150 mg/kg body weight EHA.
*Values are means + standard error of mean of 5 animals per group. Values
with different superscripts along the column are significantly different (P < .05).
Table 2. Effect of Ethanol Extract of Artocarpus heterophyllus on Serum
Insulin, HOMA-IR, and HOMA-b*.
Group Insulin (pmol/L) HOMA-IR HOMA-b
ND 143.44+ 1.50a 4.16+ 0.01a 81.93 + 2.20a
D 50.48+ 0.28e 5.36+ 0.03d 4.71 + 0.16e
GLI5 100.28+ 0.60d 3.38+ 0.41c 47.80 + 1.46d
EHA50 110.24+ 0.05c 3.58+ 0.33b 55.16 + 1.56c
EHA100 126.41+ 0.18b 3.85+ 0.22b 68.27 + 0.72b
EHA150 141.94+ 1.24a 4.11+ 0.25a 81.13 + 1.29a
Abbreviations: ND, control rats received distilled water; D, alloxan-induced
diabetic rats received distilled water; GLI5, Diabetic rats received glibencla-
mide (5 mg/kg body weight); EHA50, diabetic rats received 50 mg/kg body
weight EHA; EHA100, diabetic rats received 100 mg/kg body weight EHA;
EHA150, diabetic rats received 150 mg/kg body weight EHA; HOMA-IR,
Homeostatic Model Assessment–Insulin Resistance; HOMA-b, Homeostatic
Model Assessment b-cell.
*Values are means + standard error of the mean of 5 animals per group.
Values with different superscripts along the column are significantly different
(P < .05).
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Table 3. Effects of Ethanol Extract of Artocarpus heterophyllus on Liver Antioxidant Enzyme Activities and MDA Levels in Alloxan-Induced
Diabetic Rats*.
Groups SOD (U/mg protein) GPx (nm/min/mg) CAT (U/mg protein) MDA (109 mmol/mL)
ND 10.2+ 1.10a 86.209+0.10a 7.42 + 0.19a 1.02+ 0.01a
D 2.10+ 0.01e 24.62+1.10e 1.26 + 0.13e 4.92+ 0.20e
GLI5 4.20+ 1.10d 38.49+ 2.10d 3.42 + 1.19d 2.88+ 1.22d
EHA50 6.32+ 1.42c 62.10+ 1.10c 5.20 + 0.10c 1.89+ 0.12c
EHA100 9.04+ 0.01b 64.78+ 2.10b 6.42 + 0.09b 1.22+ 0.14b
EHA150 9.89+ 1.01a 84.98+ 2.04a 7.56 + 0.15 a 1.08+ 1.14a
Abbreviations: SOD, superoxide dismutase; CAT, catalase; GPx, glutathione peroxidase; MDA, malondialdehyde; ND, control rats received distilled water; D,
alloxan-induced diabetic rats received distilled water; GLI5, Diabetic rats received glibenclamide (5 mg/kg body weight); EHA50, diabetic rats received 50 mg/kg
body weight EHA; EHA100, diabetic rats received 100 mg/kg body weight EHA; EHA150, diabetic rats received 150 mg/kg body weight EHA.
*Values are means + standard error of mean of 5 animals per group. Values with different superscripts along the column are significantly different (P < .05).
Figure 1. Histopathological studies of pancreas. (Plate 1) Pancreas section of normal control rat parenchymal cells and islet cells. (Plate 2)
Pancreas section of diabetic control rats showing mild hyperplasia of islet cells with mild infiltration of inflammatory cells, reduction in b islets
cells with dilated and atropic islets. (Plate 3) Pancreas section of diabetic þ 50 mg/kg Artocarpus heterophyllus treated rats showing absence of
ballooning, inflammatory cells, and regeneration of pancreas toward near normal architecture. (Plate 4) Pancreas section of diabeticþ 100 mg/kg
Artocarpus heterophyllus treated rats showing pancreatic islets indicating normal pancreas. (Plate 5) Pancreas section of diabetic þ 150 mg/kg
Artocarpus heterophyllus treated rats pancreatic islets of normal pancreas. (Plate 6) Pancreas section of diabetic þ glibenclamide treated rats
showed almost normal pancreas histology.
Ajiboye et al 541
significant (P < .05) reduction in HOMA-IR levels was noticed
in diabetes þ 5 mg/kg glibenclamide, diabetes þ 50 mg/kg
EAH, diabetes þ 100 mg/kg EAH, and diabetes þ 150 mg/
kg þ EAH groups when compared to the level of insulin in the
diabetes control group.
Oxidative stress was assessed by determining the levels of
antioxidant enzymes (SOD, GPx, and CAT) as well as mal-
ondialdehyde (MDA), a measure of lipid peroxidation in the
liver of alloxan-induced diabetic rats, as shown in Table 3.
The untreated diabetic rats (diabetes control) showed signif-
icantly (P < .05) reduced liver SOD, GPx, and CAT (P < .05)
activities compared to the nondiabetic rats (normal control)
and treated groups. Treatment with EAH (at various concen-
trations) significantly (P < .05) increased the activities of
SOD, GPx, and CAT. The diabetic control group showed a
significant (P < .05) increase in liver MDA levels, compared
to the normal control, whereas diabetic rats treated with EAH
reduced the MDA levels in a concentration-dependent man-
ner of EAH.
Moreover, the histopathological studies of the pancreas of
nondiabetic rats (control rats) showed normal histology
(Figure 1, Plate 1). Diabetic untreated rat shows degeneration
of pancreatic b-cell (Figure 1, Plate 2). The diabetic group
treated with 5 mg/kg glibenclamide showed almost normal
pancreas histology (Figure 1, Plate 6), while the diabetic rats
treated with various doses of EAH stem bark showed signifi-
cant improvement in the regeneration of damaged b-cells of
pancreas in concentration-dependent manners (Figure 1,
Plates 3-5).
Discussion
In this study, the effects of oral administration of various doses
of EAH stem bark in alloxan-induced diabetes rats was inves-
tigated through a 3-week posttreatment period. The reduction
in fasting blood glucose levels of diabetic rats treated with
varied doses of the EAH stem bark showed that the extract
possessed antihyperglycemic properties, which may be proba-
bly due to the antioxidative nature of the plant.19
Diabetes is a heterogeneous disorder characterized by
decrease in insulin secretion due to pancreatic b-cell dysfunc-
tion in response to hyperglycemia.20 In this study, decreased
insulin levels and loss of b-cell integrity were observed in the
alloxan-induced diabetic rats. However, at the end of 21 days of
treatment, these were ameliorated in both EAH stem bark and
glibenclamide rats with restoration of the pancreatic morphol-
ogy to normal. This increased serum insulin levels could be due
to regeneration of pancreatic b islets observed in the histologi-
cal studies of the pancreas, which has been additionally sup-
ported by the significantly higher HOMA-b index (b-cell
function) in the treated groups compared to the diabetes control
group. The significant reduction in HOMA-IR index in diabetic
rats treated with various doses of EAH stem bark confirmed the
improvement of insulin sensitivity as well as the stimulation of
peripheral glucose absorption in these groups. Therefore, the
antihyperglycemic effect of EAH stem bark could be attributed
to the presence of phenol in the extract, which possesses anti-
oxidative potential.19
Lipid peroxidation is one of the characteristic features of
chronic diabetes.21,22 The increased lipid peroxidation during
diabetes, as found in the present study, may be due to the
inefficient antioxidant system prevalent in diabetes. The status
of lipid peroxidation as well as altered levels of certain endo-
genous radical scavenger was taken as evidence for oxidative
stress.23 Free radical scavenging enzymes like SOD, GPx, and
CAT protect the biological system from oxidative stress.24
The decrease in activity of the enzymes in the present study
could be attributed to the excessive utilization of these
enzymes in attenuating the free radicals generated during dia-
betes mellitus. Previous reports have shown an elevation in
the status of lipid peroxidation in the liver after alloxan induc-
tion,25 which was in accordance with the findings of this
study. The activities of antioxidant enzymes observed in dia-
betic rats treated with EAH stem bark could have prevented
reactive oxygen species from causing further damage to mem-
brane lipids.
Conclusion
Various doses of Artocarpus heterophyllus stem bark possess
strong antidiabetic activity via reducing fasting blood glu-
cose, improved insulin sensitivity, amelioration of pancreatic
b-cell and b-cell functions, reduced lipid peroxidation, and
improved antioxidant enzymes activities in diabetic rats. This
may be probably ascribed to the antioxidative nature of the
plant.
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